Welcure Drugs & Pharmaceuticals Ltd — Board Meeting, 29-05-2025: Board Meeting

Welcure Drugs & Pharmaceuticals Ltd has announced a board meeting on which approved the financial results for the quarter and half-year. The company reported total revenue of ₹2645.99 Lacs and a net profit of ₹217.01 Lacs for the year ended March 31, 2025. The auditor issued a disclaimer of opinion due to lack of sufficient audit evidence, citing unconfirmed unsecured loans of ₹8472.96 Lacs, unverified GST credit of ₹4.65 Lacs, unconfirmed advances of ₹1943.84 Lacs, and borrowings of ₹12,319.89 Lacs. Inventory valuation of ₹14,352.36 Lacs could not be verified since goods are directly traded without warehouse evidence. These audit qualifications raise concerns over financial transparency and reliability. Vishakha Agrawal & Associates were appointed as Secretarial Auditor for FY 2024-25.